{"id":"W4389745521","doi":"10.1097/js9.0000000000000698","title":"FDA grants approval to the RSV vaccine (nirsevimab-alip) for all infants: a leap forward for shielding the smallest","year":2023,"lang":"en","type":"editorial","venue":"International Journal of Surgery","topic":"Respiratory viral infections research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Respiratory tract infections; Respiratory tract; Pediatrics; Respiratory system; Lower respiratory tract infection; Palivizumab; Disease; Virus; Pathogen; Intensive care medicine; Immunology; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004199962,0.0007027381,0.0007820529,0.0005805232,0.0009773895,0.001991563,0.001139499,0.007390953,0.04015065],"category_scores_gemma":[0.008486961,0.0002854578,0.001319765,0.0004646608,0.001060883,0.001680191,0.0009735558,0.008067233,0.01376201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001725641,"about_ca_system_score_gemma":0.005214664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002881714,"about_ca_topic_score_gemma":0.006631984,"domain_scores_codex":[0.9969976,0.0006308532,0.0001482762,0.0002259696,0.001591021,0.0004061746],"domain_scores_gemma":[0.9917489,0.001519117,0.0005001226,0.0003228353,0.003352337,0.002556746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002741185,0.0001396769,0.0004659907,0.0001917124,0.00002361637,0.0003382436,0.00003956364,0.00007891955,0.001988757,0.005992945,0.8357082,0.1547584],"study_design_scores_gemma":[0.0002927918,0.0003734129,0.0009220446,0.0002535482,0.00001571431,0.0004165374,0.0000254196,0.00008204874,0.0003245821,0.001123118,0.9961569,0.0000138673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.006213188,0.03949741,0.003618018,0.7174118,0.0390642,0.0004710923,0.002618264,0.0011879,0.1899182],"genre_scores_gemma":[0.09295708,0.08084964,0.01829859,0.5324133,0.04585712,0.000791325,0.007542391,0.0006766702,0.220614],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.04015065,"threshold_uncertainty_score":0.1343173,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1040237797093715,"score_gpt":0.4233084776224863,"score_spread":0.3192846979131149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}